AMITIZA, THE FIRST SELECTIVE CHLORIDE CHANNEL ACTIVATOR FOR THE TREATMENT OF CHRONIC IDIOPATHIC CONSTIPATION
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals
North America, Inc., announced today that AMITIZA (lubiprostone), 24-mcg soft-gel
capsules, approved by the U.S. Food and Drug Administration (FDA) in January 2006,
is now available by prescription in pharmacies across the United States for the
treatment of chronic idiopathic constipation in adults.